November 08, 2019 at 04:43PM Guidance for Industry Postmarketing Studies and Clinical Trials — Implementation of Section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act

Drug Safety

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2PZXYSj